Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2006 1
2007 1
2008 1
2009 3
2012 3
2013 3
2014 2
2015 2
2016 3
2018 2
2019 5
2020 4
2021 3
2022 1
2023 4
2024 4
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial.
Martínez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvadó J, San Julián B, Sanchez-Tainta A, Ros E, Valls-Pedret C, Martinez-Gonzalez MÁ. Martínez-Lapiscina EH, et al. Among authors: clavero p. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1318-25. doi: 10.1136/jnnp-2012-304792. Epub 2013 May 13. J Neurol Neurosurg Psychiatry. 2013. PMID: 23670794 Free article. Clinical Trial.
Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity.
Ayerra L, Abellanas MA, Basurco L, Tamayo I, Conde E, Tavira A, Trigo A, Vidaurre C, Vilas A, San Martin-Uriz P, Luquin E, Clavero P, Mengual E, Hervás-Stubbs S, Aymerich MS. Ayerra L, et al. Among authors: clavero p. J Neuroinflammation. 2024 Apr 12;21(1):92. doi: 10.1186/s12974-024-03091-x. J Neuroinflammation. 2024. PMID: 38610019 Free PMC article.
Dysphagia in Parkinson´s disease. A 5-year follow-up study.
Santos-García D, de Deus Fonticoba T, Jesús S, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Pareés I, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Seijo M, Valero C, Alonso Redondo R, Ordás C, Menéndez-González M, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Neurol Sci. 2025 Jun;46(6):2637-2653. doi: 10.1007/s10072-025-08027-8. Epub 2025 Feb 19. Neurol Sci. 2025. PMID: 39969751 Free PMC article.
Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline.
Rodríguez-Antigüedad J, Martínez-Horta S, Puig-Davi A, Horta-Barba A, Pagonabarraga J, de Deus Fonticoba T, Jesús S, Cosgaya M, García Caldentey J, Ávila-Rivera MA, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Gómez Mayordomo V, González Ardura J, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Pareés I, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Ruíz Martínez J, Buongiorno MT, Ordás C, Valero C, Puente V, Kurtis M, Blázquez Estrada M, Martínez-Martín P, Mir P, Santos-García D; COPPADIS Study Group; Kulisevsky J. Rodríguez-Antigüedad J, et al. J Neurol. 2025 Mar 5;272(3):246. doi: 10.1007/s00415-024-12808-0. J Neurol. 2025. PMID: 40042541 Free PMC article.
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.
Santos-García D, de Deus T, Cores C, Feal Painceiras MJ, Íñiguez Alvarado MC, Samaniego LB, López Maside A, Jesús S, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández-Vara J, Cabo López I, López Manzanares L, González-Aramburu I, Ávila A, Gómez-Mayordomo V, Nogueira V, Dotor García-Soto J, Borrué-Fernández C, Solano B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Pareés I, Sánchez Alonso P, Alonso Losada MG, López-Ariztegui N, Gastón I, Kulisevsky J, Seijo M, Valero C, Alonso Redondo R, Buongiorno MT, Ordás C, Menéndez-González M, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Mov Disord Clin Pract. 2024 Jul;11(7):830-849. doi: 10.1002/mdc3.14056. Epub 2024 May 15. Mov Disord Clin Pract. 2024. PMID: 38747234 Free PMC article.
Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.
Ayerra L, Abellanas MA, Vidaurre C, Basurco L, Tavira A, Luquin E, Clavero P, Mengual E, Collantes M, Peñuelas I, de Martin-Esteban SR, Grether U, Hillard CJ, Romero J, Hervás-Stubbs S, Aymerich MS. Ayerra L, et al. Among authors: clavero p. Brain Behav Immun. 2025 Aug;128:600-611. doi: 10.1016/j.bbi.2025.04.037. Epub 2025 May 2. Brain Behav Immun. 2025. PMID: 40320016 Free article.
Subspace corrected relevance learning with application in neuroimaging.
van Veen R, Tamboli NRB, Lövdal S, Meles SK, Renken RJ, de Vries GJ, Arnaldi D, Morbelli S, Clavero P, Obeso JA, Oroz MCR, Leenders KL, Villmann T, Biehl M. van Veen R, et al. Among authors: clavero p. Artif Intell Med. 2024 Mar;149:102786. doi: 10.1016/j.artmed.2024.102786. Epub 2024 Jan 24. Artif Intell Med. 2024. PMID: 38462286 Free article.
[Opicapone for the treatment of Parkinson's disease: real-life data in Spain].
López-Ariztegui N, Mata-Alvarez Santullano M, Tegel I, Almeida F, Sarasa P, Rojo R, Rico-Villademoros F, Abril-Jaramillo J, Bermejo P, Borrue C, Caballol N, Campins-Romeu M, Clavero P, García-Caldentey J, Gómez-Mayordomo V, Labandeira C, Martí-Andrés G, Martínez-Castrillo JC, Martinez-Poles J, Muñoz T, Salom JM, Valderrama-Martín C, Vinagre-Aragón A. López-Ariztegui N, et al. Among authors: clavero p. Rev Neurol. 2021 Dec 24;73(s02):S01-S14. doi: 10.33588/rn.73s02.2021461. Rev Neurol. 2021. PMID: 34897643 Free article. Review. Spanish.
46 results